Elevate expression with the GSquad® Pro vector system

At Lonza, we continually invest in innovation covering all platform elements to help ensure that we keep one step ahead of the output from drug discovery groups. To ensure that the genetic instructions delivered into CHO cells at transfection can leverage the maximum biosynthetic capability out of the host cell factory, Lonza has been further developing its GS® expression vector technology. We have developed a novel high-strength synthetic, hybrid gene promoter (LHP-1) that affords increased titers for a range of molecules, relative to the standard mCMV promoter, whilst maintaining excellent product quality and expression stability.